C 646

Based on 20 reference(s) in Google Scholar 80 100 20

Axon 1781

CAS [328968-36-1]

MF C24H19N3O6
MW 445.42

C 646

Description

Competitive p300/CBP histone acetyltransferase (HAT) inhibitor with a Ki of 400 nM; Selective versus other acetyltransferases

Cell Signaling & Oncology Epigenetics HAT EC 2.3.1.48

HAT inhibitor (p300/CBP selective)

4-(4-((5-(4,5-dimethyl-2-nitrophenyl)furan-2-yl)methylene)-3-methyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl)benzoic acid

[328968-36-1]

Order

Need more? Bulk Inquiry

Axon ID	Name	Description
1490	Anacardic acid A	HAT inhibitor	€60.00
1785	MG 149	HAT inhibitor (Tip60 and MOZ specific)	€90.00
2208	Gallic acid	Multi-affinity drug. Antioxidant.	€50.00
2299	Remodelin	Potent NAT 10 inhibitor that mediates nuclear shape rescue in laminopathic cells via microtubule reorganization	€90.00
2319	L 002	Inhibitor of p300 HAT (KAT3B) and p53 acetylation	€80.00
2339	TH 1834	Tip60 histone acetyltransferase inhibitor	€140.00
2568	EML 425	Potent reversible dual inhibitor of CBP and p300 (HAT/KAT3)	€95.00
2765	CPTH2	HAT inhibitor (Gcn5p specific)	€125.00
2969	WM-1119	Highly potent and selective KAT6A inhibitor	€130.00
3959	JG-2016	First inhibitor of the HAT1 enzyme complex	€140.00
4127	GNE-781	Highly potent, selective, and orally bioavailable CBP inhibitor	€160.00
4011	MC4171	First-in-class potent and selective KAT8 inhibitor	€130.00